GGrantIndex
Sort

53,477 grants matching addiction

Dynamic control of cue-driven behavior via the paraventricular thalamic nucleus

$528,902
Shelly Beth Flagel · University Of Michigan At Ann Arbor · R01 · FY2016 · DA

Brain Acetate and Ethanol Metabolism in Alcohol Dependence and Abuse

$528,898
Graeme F Mason · Yale University · R01 · FY2015 · AA

Health & Psychosocial Need: Children with Developmental Disorder in a Time of HIV

$528,888
Leslie L. Davidson · Columbia University Health Sciences · R01 · FY2007 · DA

ADMINISTRATIVE AND SCIENTIFIC CORE

$528,872
Frederick Gerard Moeller · University Of Texas Hlth Sci Ctr Houston · P50 · FY2008 · DA

Mechanisms driving lung cancer evolution during targeted kinase inhibitor treatment

$528,861
Aaron N Hata · Massachusetts General Hospital · R01 · FY2024 · CA

Imaging Nociceptin Receptors in Alcoholism

$528,840
Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AA

Alcohol Actions-Molecular Targets on Brain Proteins

$528,809
Robert Adron Harris · University Of Texas At Austin · R01 · FY2011 · AA

Methodology and measurement for examining short-term and long-term effects of e-cigarette and polysubstance use

$528,804
Yuh-Pey Anne Buu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · DA

Inhibitory Cell Types and Circuits in the Lateral Hypothalamus

$528,771
Alexander Choi Jackson · University Of Connecticut Storrs · R01 · FY2025 · MH

Muscarinic acetylcholine receptor subtypes: physiological roles

$528,731
Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Project 1: Using toxicity testing data to test hypotheses about advanced-generation ECIGs and generate population-level predictions regarding potential regulatory action

$528,726
Alan Shihadeh · Virginia Commonwealth University · U54 · FY2020 · DA

Genomic Resource Grant for PhenX Toolkit (U41)

$528,723
Carol M Hamilton · Research Triangle Institute · U41 · FY2014 · HG

Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain

$528,713
Corey R. Hopkins · University Of Nebraska Medical Center · R01 · FY2023 · NS

TREATMENT OF ADULT ADHD IN METHADONE PATIENTS

$528,706
New York State Psychiatric Institute · R01 · FY2002 · DA

Regulatory Impact on Vape Shops and Young Adults' Use of ENDS

$528,700
Carla J Berg · George Washington University · R01 · FY2022 · CA

Abuse liability of reduced nicotine content cigarettes within a complex tobacco marketplace

$528,640
Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2016 · DA

Mid Southern Primary Care Networks Node

$528,610
Li-Tzy T Wu · Duke University · UG1 · FY2018 · DA

PHARMACOKINETICS OF NICOTINE IN TWINS

$528,601
Sri International · R01 · FY2000 · DA

Low Nicotine Content Cigarettes in Vulnerable Populations: Economically Disadvantaged Women (Non-Pregnant)

$528,574
Stephen T Higgins · University Of Vermont & St Agric College · U54 · FY2022 · DA

Personalized Health Assessment Related to Medications (Project PHARM)

$528,559
Jason Robert Kilmer · University Of Washington · U01 · FY2019 · DA

Evaluating Coordinated Care Organizations

$528,502
Kenneth John McConnell · Oregon Health & Science University · R01 · FY2013 · MH

Structural Analysis of Alcohol-dependent Activation of GIRKs

$528,489
Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AA

Training Program: Drugs of Abuse & Related Neuropeptides

$528,482
Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2020 · DA

Research Project 2

$528,475
Jennifer Rai Richards · Johns Hopkins University · P50 · FY2024 · DA

Graphic and text-based waterpipe warning labels to combat harm misperceptions

$528,397
Amy K Ferketich · Ohio State University · R01 · FY2019 · CA